854 results on '"Lo, Chung Mau"'
Search Results
2. High prevalence of de novo metabolic dysfunction-associated fatty liver disease after liver transplantation and the role of controlled attenuation parameter
3. Arachidonic acid activates NLRP3 inflammasome in MDSCs via FATP2 to promote post-transplant tumour recurrence in steatotic liver grafts
4. Stereotactic Body Radiotherapy and Liver Transplant for Liver Cancer
5. The role of stereotactic body radiotherapy in hepatocellular carcinoma: guidelines and evidences
6. Impact of preoperative biliary drainage on postoperative outcomes in hilar cholangiocarcinoma
7. Role of Intrahepatic Regional Immunity in Post-Transplant Cancer Recurrence
8. Glutathione S-transferase A2 promotes hepatocellular carcinoma recurrence after liver transplantation through modulating reactive oxygen species metabolism
9. Regional trauma system development in Shenzhen, China: an 8-year journey
10. Interferon-gamma inducible protein 10 (IP10) induced cisplatin resistance of HCC after liver transplantation through ER stress signaling pathway
11. Survival analysis of breast cancer liver metastasis treated by hepatectomy: A propensity score analysis for Chinese women in Hong Kong
12. Donor ductal anomaly is not a contraindication to right liver lobe donation
13. Comparison of clinical outcome between stereotactic body radiotherapy and radiofrequency ablation for unresectable hepatocellular carcinoma
14. Long-term survival comparison between primary transplant and upfront curative treatment with salvage transplant for early stage hepatocellular carcinoma
15. Major postoperative complications compromise oncological outcomes of patients with intrahepatic cholangiocarcinoma after curative resection – A 13-year cohort in a tertiary center
16. Solitary extraovarian primary peritoneal carcinoma with direct invasion into the liver, diaphragm and lung without peritoneal dissemination or distant metastasis
17. Monocytic MDSC mobilization promotes tumor recurrence after liver transplantation via CXCL10/TLR4/MMP14 signaling
18. Performance of Dual-tracer PET-CT for Staging Post–Liver Transplant Hepatocellular Carcinoma Recurrence
19. A machine learning model for colorectal liver metastasis post-hepatectomy prognostications
20. Donor-Derived Genotype 4 Hepatitis E Virus Infection, Hong Kong, China, 2018
21. Rat Hepatitis E Virus as Cause of Persistent Hepatitis after Liver Transplant
22. The Landscape of Aberrant Alternative Splicing Events in Steatotic Liver Graft Post Transplantation via Transcriptome-Wide Analysis
23. Hepatopancreatoduodenectomy for advanced hepatobiliary malignancies: a single-center experience
24. Resection of T4 hepatocellular carcinomas with adjacent structures, is it justified?
25. Defining the optimal bilirubin level before hepatectomy for hilar cholangiocarcinoma
26. Pneumocystis jirovecii-related spontaneous pneumothorax, pneumomediastinum and subcutaneous emphysema in a liver transplant recipient: a case report
27. Development and validation of an artificial intelligence model for predicting post‐transplant hepatocellular cancer recurrence.
28. Glucose deprivation-induced aberrant FUT1-mediated fucosylation drives cancer stemness in hepatocellular carcinoma
29. New insights after the first 1000 liver transplantations at The University of Hong Kong
30. Acute pancreatitis induced by transarterial chemoembolization: a single-center experience of over 1500 cases
31. Adjuvant chemotherapy improves oncological outcomes of resectable intrahepatic cholangiocarcinoma: A meta-analysis
32. Clinical factors affecting rejection rates in liver transplantation
33. Impact of tumor biology on outcomes of radical therapy for hepatocellular carcinoma oligo-recurrence after liver transplantation
34. Verifying the benefits of radical treatment in posttransplant hepatocellular carcinoma oligo-recurrence: a propensity score analysis
35. Postoperative Plasmacytoid Dendritic Cells Secrete IFNα to Promote Recruitment of Myeloid-Derived Suppressor Cells and Drive Hepatocellular Carcinoma Recurrence
36. Recurrent pyogenic cholangitis: An indication for liver transplantation
37. Good longterm survival after primary living donor liver transplantation for solitary hepatocellular carcinomas up to 8 cm in diameter
38. Perpetuating proficiency in donor right hepatectomy for living donor liver transplantation
39. Impact of Tumour Biology on Outcomes of Radical Therapy for Hepatocellular Carcinoma Oligo-Recurrence after Liver Transplantation
40. An International Retrospective Observational Study of Liver Functional Deterioration after Repeat Liver Resection for Patients with Hepatocellular Carcinoma
41. Retrohepatic vena cava deroofing in living donor liver transplantation for caudate hepatocellular carcinoma
42. Prevention of recurrent hepatitis B infection after liver transplantation
43. Survival analysis of high‐intensity focused ultrasound ablation in patients with small hepatocellular carcinoma
44. Outcomes of central bisectionectomy for hepatocellular carcinoma
45. Survival outcomes of right-lobe living donor liver transplantation for patients with high Model for End-stage Liver Disease scores
46. Evaluation of the seventh edition of the American Joint Committee on Cancer tumour–node–metastasis (TNM) staging system for patients undergoing curative resection of hepatocellular carcinoma: implications for the development of a refined staging system
47. Outcomes of side-to-side conversion hepaticojejunostomy for biliary anastomotic stricture after right-liver living donor liver transplantation
48. A new formula for estimation of standard liver volume using computed tomography–measured body thickness
49. Survival outcomes of hepatocellular carcinoma resection with postoperative complications – a propensity-score-matched analysis
50. Radiological prognosticators of hepatocellular carcinoma treated by hepatectomy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.